We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

24 hedge funds and large institutions have $1.77M invested in Albireo Pharma Inc in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

17% less funds holding

Funds holding: 29 → 24 (-5)

24% less capital invested

Capital invested by funds: $2.34M → $1.77M (-$565K)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
24
Holders Change
-5
Holders Change %
-17.24%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
6
Closed
6
Calls
$24K
Puts
–
Net Calls
+$24K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$64.1K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$27.2K
3
Citadel Advisors
Citadel Advisors
Florida
+$23K
4
VKH
Virtu KCG Holdings
New York
+$16.4K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$13.3K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$318K
2
SM
Sabby Management
Florida
-$118K
3
Deutsche Bank
Deutsche Bank
Germany
-$75.8K
4
BFA
BlackRock Fund Advisors
California
-$42.2K
5
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$27K

ALBO Hedge Fund Activity: Q2 2016 in Review

24 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2016, worth a combined $1.77M — down 24% from $2.34M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ALBO and 1 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $64.1K. The largest seller was Fidelity Investments, exiting entirely with an estimated $318K sold.

  • 24 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2016, down from 29 in Q1 2016.
  • Funds reported $1.77M of Albireo Pharma Inc stock for Q2 2016, down 24% quarter-over-quarter.
  • 1 fund opened new Albireo Pharma Inc positions in Q2 2016 and 6 closed out, a net change of -5 holders.
  • The largest Albireo Pharma Inc buyer in Q2 2016 was Renaissance Technologies, an estimated $64.1K added.
  • The largest Albireo Pharma Inc seller in Q2 2016 was Fidelity Investments, an estimated $318K sold.

Based on aggregated 13F filings for Q2 2016.